Atrion Corporation (ATRI)

209.29 +0.34  +0.16%  May 17, 8:00PM
Add to Watchlists Create an Alert

Atrion Corporation R&D Expense Quarterly:

1.197M for Dec. 31, 2012
View Full Chart

Atrion Corporation R&D Expense Quarterly Chart

    Atrion Corporation Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 1.197M
    Sept. 30, 2012 0.753M
    June 30, 2012 0.844M
    March 31, 2012 0.973M
    Dec. 31, 2011 0.785M
    Sept. 30, 2011 0.778M
    June 30, 2011 0.728M
    March 31, 2011 0.576M
    Dec. 31, 2010 0.619M
    Sept. 30, 2010 0.76M
    June 30, 2010 0.675M
    March 31, 2010 0.615M
    Dec. 31, 2009 0.863M
    Sept. 30, 2009 0.661M
    June 30, 2009 0.76M
    March 31, 2009 0.77M
    Dec. 31, 2008 0.728M
    Sept. 30, 2008 0.63M
    June 30, 2008 0.823M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    ATRI R&D Expense Quarterly Benchmarks

    Companies
    Becton Dickinson 122.38M
    Intuitive Surgical 41.60M
    Staar Surgical 1.366M

    ATRI R&D Expense Quarterly Rankings

    Overall 83rd percentile
    1216 of 7590
    Sector 43rd percentile
    367 of 651 in Healthcare
    Industry 31st percentile
    46 of 67 in Medical Instruments & Supplies

    ATRI R&D Expense Quarterly Range, Past 5 Years

    Minimum 0.5760M Mar 2011
    Maximum 1.197M Dec 2012
    Average 0.7652M